Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

Crohn’s Disease can affect any part of the gastrointestinal tract, but most commonly targets the terminal ileum and proximal colon. A key characteristic of Crohn’s is transmural involvement, meaning ...

Silent Crohn’s disease' is a form of inflammatory bowel disease that may develop without typical or obvious symptoms.

If you live with Crohn’s disease, you’re already familiar with the incessant fatigue, abdominal pain, and diarrhea that comes along with a Crohn’s diagnosis. Crohn’s is an autoimmune disorder that ...

Common unpleasant symptoms after eating too much of the wrong thing happen to just about anyone. Cramping, nausea, abdominal pain or gas typically don’t last long, but if you have Crohn’s disease, ...

Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new mechanisms of action such as interleukin inhibitors and Janus kinase inhibitors.

Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the digestive tract, often causing abdominal pain, persistent diarrhea, rectal bleeding, weight loss, and fatigue during ...

If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, roughly 1 million people in the United States are living with this digestive ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Antwerp, Belgium, November 17, 2025 - Agomab Therapeutics NV (‘Agomab’) today announced positive data from 103 participants completing 12 weeks of treatment in the STENOVA1 Phase 2a clinical trial for ...